<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02806089</url>
  </required_header>
  <id_info>
    <org_study_id>UF9639</org_study_id>
    <nct_id>NCT02806089</nct_id>
  </id_info>
  <brief_title>Determinants of Muscle Strength in Chronic Kidney Disease</brief_title>
  <official_title>Determinants of Muscle Strength in Chronic Kidney Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of this study is to determine in chronic kidney disease patients:

        -  the involvement of malnutrition inflammation and atherogenesis syndrome (increase in C
           reactive protein and decrease in serum albumin) on voluntary muscle strength impairment

        -  the relationship between voluntary muscle strength and muscle mass

        -  the relationship between voluntary muscle strength and lean body mass

        -  the correlation between voluntary muscle strength and physical activity
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim of this study is to determine in chronic kidney disease patients:

        -  the involvement of malnutrition inflammation and atherogenesis syndrome (increase in C
           reactive protein and decrease in serum albumin) on voluntary muscle strength impairment
           (estimated by handheld dynamometer)

        -  the relationship between voluntary muscle strength and muscle mass (estimated by
           creatinine index)

        -  the relationship between voluntary muscle strength and lean body mass (estimated by
           bioelectrical impedance analysis)

        -  the correlation between voluntary muscle strength and physical activity (the physical
           activity being estimated by the &quot;Voorrips&quot; score questionnaire)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 4, 2016</start_date>
  <completion_date type="Actual">October 2017</completion_date>
  <primary_completion_date type="Actual">June 14, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Voluntary muscle strength evaluated by handheld dynamometer</measure>
    <time_frame>1 day</time_frame>
    <description>data will be measured in Newton.meter</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Muscle mass estimated by creatinine index evaluation</measure>
    <time_frame>1 day</time_frame>
    <description>data will be obtained from plasma creatinine level and will be expressed in milligram/kilogram/day)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lean body mass evaluated by electrical bioimpedance analysis</measure>
    <time_frame>1 day</time_frame>
    <description>data will be expressed in kilogram</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical activity estimated using the &quot;Voorrips&quot; score questionnaire</measure>
    <time_frame>1 day</time_frame>
    <description>the score represents the daily physical activity according to a validated scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>C reactive protein level</measure>
    <time_frame>1 day</time_frame>
    <description>the parameter will be measured in milligram/liter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Albumin level</measure>
    <time_frame>1 day</time_frame>
    <description>the parameter will be measured in gram/liter</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">110</enrollment>
  <condition>Chronic Kidney Disease</condition>
  <arm_group>
    <arm_group_label>Muscle strength</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>single evaluation (the day of inclusion) of muscle strength (by handheld dynamometer), muscle mass (by creatinine index estimation), lean body mass (by electrical bioimpedance analysis), physical activity (by &quot;Voorrips&quot; score questionnaire), inflammatory and nutritional status.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Handheld dynamometer</intervention_name>
    <description>Evaluation of muscle strength</description>
    <arm_group_label>Muscle strength</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Creatinine index</intervention_name>
    <description>Evaluation of muscle mass using plasma creatinine level</description>
    <arm_group_label>Muscle strength</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Electrical bioimpedance analysis</intervention_name>
    <description>Evaluation of lean body mass</description>
    <arm_group_label>Muscle strength</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>&quot;Voorrips&quot; score questionnaire</intervention_name>
    <description>Evaluation of physical activity</description>
    <arm_group_label>Muscle strength</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Inflammatory and nutritional status</intervention_name>
    <description>Evaluation of C reactive protein and albumin</description>
    <arm_group_label>Muscle strength</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  chronic kidney disease patient with extrarenal replacement therapy by hemodialysis for
             at least 3 months

          -  stable clinical condition (absence of infection, stroke or acute decompensation)

        Exclusion Criteria:

          -  chronic kidney disease without extrarenal replacement therapy

          -  history of renal transplantation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Paul CRISTOL, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Lapeyronie, Department of Biochemistry and Hormonology, Montpellier, FRANCE</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>AIDER</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GCS Help Lapeyronie, CHU Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AIDER</name>
      <address>
        <city>NÃ®mes</city>
        <zip>30900</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <study_first_submitted>June 6, 2016</study_first_submitted>
  <study_first_submitted_qc>June 15, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 20, 2016</study_first_posted>
  <last_update_submitted>February 26, 2019</last_update_submitted>
  <last_update_submitted_qc>February 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>chronic kidney disease</keyword>
  <keyword>malnutrition inflammation atherogenesis syndrome</keyword>
  <keyword>muscle strength</keyword>
  <keyword>muscle mass</keyword>
  <keyword>lean body mass</keyword>
  <keyword>physical activity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

